4016 fundamentals
MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. financial statements, including revenue, expenses, and profit
The total revenue of 4016 for the last quarter is 135.99 M SAR, and it's 67.76% higher compared to the previous quarter. The net income of Q4 24 is 44.81 M SAR.
Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: SAR
Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM